Publication

Article

Pharmaceutical Technology

Pharmaceutical Technology-01-02-2010
Volume34
Issue 1

Pharmaceutical Technology North America, January 2010 (PDF)

Quality by Design, Deficiencies in Generic Drug Applications, API Growth, Topical Berberine-Hydrochloride Products

.

External Link - PT0110.pdf

Articles in this issue
A Perspective from FDA on ICH Q10 Pharmaceutical Quality System for Contract Manufacturers
i8_t-651903-1408632451149.jpg
Understanding Biological Indicator Grow-Out Times
The Formulation and Evaluation of Topical Berberine-Hydrochloride Products
The Formulation and Evaluation of Topical Berberine-Hydrochloride Products
i1-651072-1408633198097.jpg
Healthcare Reform Requires Room for Innovation
i3_t-651070-1408633202752.jpg
Pharma Faces Multiple Challenges in the Year Ahead
i1-651066-1408633214424.jpg
A Look Ahead for 2010
In the Field: Report from Brazil
In the Field: Report from Brazil
GSK Gets under Your Skin
Tracking API Growth
Tracking API Growth
i4-651069-1408633204665.jpg
Statistical Solutions: %RSD: Friend or Foe?
i1-651067-1408633211877.jpg
In the Spotlight January 2010
A Mass Transfer of Knowledge
A Mass Transfer of Knowledge
FDA Perspectives: Common Deficiencies in Abbreviated New Drug Applications: Part 1: Drug Substance
FDA Perspectives: Common Deficiencies in Abbreviated New Drug Applications: Part 1: Drug Substance
AAI Pharma's Lee Karras talks about contract-service demand.
AAI Pharma's Lee Karras talks about contract-service demand.
i8_t-651078-1408633176825.jpg
A PAT Solution for Automated Mill Control

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Related Content
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
August 5th 2025

Lilly’s Kisunla Demonstrates Growing Benefit in Treating Early Alzheimer’s Disease

Feliza Mirasol
Findings from a Phase III study highlight the demonstrated action of donanemab-azbt (brand name Kisunla) in slowing the decline of patients exhibiting early symptomatic Alzheimer’s disease.
Drug Solutions Podcast: Sustainable Solutions for Biopharma
August 5th 2025

Drug Solutions Podcast: Sustainable Solutions for Biopharma

Patrick Lavery
In this podcast episode, we discuss sustainable approaches to such equipment and materials as medical propellants, flow sensor technology, and walk-in chambers, plus the critical role of women in elevating and accelerating development in these areas.
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
August 5th 2025

Roche Reveals New Data from Alzheimer’s Disease Research at AAIC 2025

Feliza Mirasol
The company presented new data from its Alzheimer’s disease research efforts across its diagnostics and pharmaceutical portfolios at this year’s AAIC.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
August 5th 2025

Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries

Patrick Lavery
In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Site Logo
August 5th 2025

Transforming the pharmaceutical value chain for emerging biotechs and large pharmas

Patheon
Integrating development, manufacturing, and research processes enhances e¬ciency and accelerates time to market
Site Logo
August 5th 2025

Value reimagined: Unlocking ROI and efficiency in drug development

Patheon